Last Week’s Important Life Science Headlines
- February 25, 2014
- Class Action,Design Defect,FDA,Litigation,Medical Device,News,Pharmaceuticals,Product Liability,Recalls,Regulatory
- 0
Litigation
- Xarelto Lawsuit Filed Over Uncontrollable Internal Bleeding
- Neomedic Cases Added to Vaginal Mesh Litigation in W.Va. Federal Court
- Endo Puts Aside $520M for Vaginal Mesh Litigation (subscription required)
- 9th Circ. Refuses to Revive Novartis Jaw Injury Litigation (subscription required)
- FTC Bags $2M False Ad Win Against Diabetes Supplement Co. (subscription required)
- J&J Mesh Suits Belong in Federal Court, 10th Circ. Told (subscription required)
- New Philly Mass Tort Program Created for Pelvic Mesh Suits (subscription required)
- J&J Wins 1st Vaginal Mesh Bellwether Trial (subscription required)
- JPML Centralizes Lipitor Diabetes Suits in SC (subscription required)
- P&G Dodges Denture Adhesive Claims in Pa. Court (subscription required)
- Injunction Likely in Case Over Diabetes Pill Ads, Judge Says (subscription required)
- J&J’s Discovery Mishap Barred from Vaginal Mesh Trial (subscription required)
- Fresenius Granuflo Lawsuit Statute of Limitations May Be Approaching
- Risperdal Lawsuit Filed by 22 Yr Old Man with Gynecomastia
- Alloderm Hernia Patch Lawsuits to be Selected for Early Trial Dates in N.J.
- Boehringer Faces 2,000-Plus Pradaxa Injury Suits (subscription required)
- 10th Circ. Told J&J Pelvic Mesh Suits Belong in State Court (subscription required)
- Sides Disagree About Trial Plan for Byetta, Januvia, Victoza Lawsuits
Regulatory
- FDA Import Reforms to Fuel Fight Over Drugmaking Slip-Ups (subscription required)
- FDA Updates Guidance on Lab Data for New Drugs (subscription required)
- FDA Eyes Overhaul of Risk Disclosure In Pharma Ads (subscription required)
- Pfizer, GSK to Have Imported Drugs Fast-Tracked By FDA (subscription required)
- FDA Warns Baxter Over Infusion Pump Quality Controls (subscription required)
- FDA Accredits ICCBBA as an Issuing Agency
- Drug Side Effect Warnings May Be Cut From Future Television Ads
- Xarelto Expanded Use Rejected Again by FDA
- HeartSine Defibrillator Problems Not Addressed: FDA
- Onglyza Heart Risks to be Reviewed by FDA
Recalls
- Agila Specialties Private Limited Initiates Voluntary Nationwide Recall of 10 Lots of Etomidate Injection 2mg/mL
- Philips Respironics Initiates Recall of Trilogy Ventilator
- Ben Venue Laboratories, Inc. Issues A Voluntary Nationwide Patient Level Recall of Acetylcysteine Solution %10, Usp, Lot 2005479
- L-citrulline by Medisca: Additional Lots Recalled
- Tandem Diabetes Care Expands Voluntary Recall for Select Lots of Insulin Cartridges Used in t:slim Insulin Pump
Leave a Comment
0 Comments
Be the first to leave a reply!